BeOne Medicines (ONC) Cash & Equivalents Growth (5y) (2020 - 2026)
BeOne Medicines (ONC) Cash & Equivalents Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Alnylam Pharmaceuticals | 37.29 Bn | 34.28 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.30% |
| Dec 31, 2025 | 26.90% |
| Sep 30, 2025 | 571.81% |
| Jun 30, 2025 | 15.43% |
| Mar 31, 2025 | 5.16% |
| Dec 31, 2024 | 519.48% |
| Sep 30, 2024 | 25.82% |
| Jun 30, 2024 | 181.89% |
| Mar 31, 2024 | 184.83% |
| Dec 31, 2023 | 193.58% |
| Sep 30, 2023 | 36.66% |
| Jun 30, 2023 | 50.72% |
| Mar 31, 2023 | 48.46% |
| Jun 30, 2022 | 76.97% |
| Mar 31, 2022 | -67.96% |
| Dec 31, 2021 | -67.28% |
| Sep 30, 2021 | 74.49% |
| Jun 30, 2021 | -64.89% |
| Mar 31, 2021 | 55.60% |
| Dec 31, 2020 | 138.60% |